Food and Drug Administration (FDA) announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the industry an opportunity to submit late new dietary ingredient (NDI) notifications. The agency intends to exercise enforcement discretion, for a limited time and in limited circumstances, to encourage manufacturers and distributors to correct any past failures to submit a required NDI notification.

NABP’s January 2021 Rogue Rx Activity Report focused on the risk of tainted dietary supplements to consumers. The report, titled Risky Dietary Supplements: How Pharmacists Can Help Protect Patients, explores adulterated dietary supplements that enter the marketplace and how pharmacists are well-positioned to provide consumers with information regarding the risks associated with these supplements.